News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ipsen (IPN.PA)’s Fourth Quarter and Full Year 2012 Sales


1/30/2013 6:09:59 AM

Regulatory News:

Ipsen (Euronext: IPN; ADR: IPSEY) reported today its sales for the fourth quarter and full year 2012.

Commenting on the full year 2012 sales performance, Marc de Garidel, Chairman and Chief Executive Officer of Ipsen said: “From the first year on, Ipsen’s drug sales performance illustrates the relevance of the Group’s strategy of focus, with specialty care up 11.3%1, growing internationally and at an accelerating pace.

Read at BioSpace.com

comments powered by Disqus
Ipsen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES